Morgan Stanley Emerging Markets Debt Fund, Inc.
MSD · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | -$0 | -$0 | $0 |
| % Growth | 283.1% | -21.7% | -183.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | -$0 | -$0 | $0 |
| % Margin | 92.1% | 113.7% | 117.4% | 81.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | $0 | -$0 | -$0 |
| % Margin | 70.6% | -103.2% | 366.2% | -37.6% |
| Other Income/Exp. Net | $0 | $0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | -$0 | -$0 |
| % Margin | 71.5% | -136% | 366.2% | -37.8% |
| EPS | 0.81 | 0.84 | -1.84 | -0.23 |
| % Growth | -3.6% | 145.7% | -700% | – |
| EPS Diluted | 0.81 | 0.84 | -1.84 | -0.23 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | -$0 | -$0 | -$0 | -$0 |
| EBITDA | $0 | $0 | -$0 | -$0 |
| % Margin | 70.6% | -45.5% | 366.2% | -37.8% |